 |
6 Diseases |  |
0 Trials |
|
0 Trials |  |
9 News |  |
- || timolol / Generic mfg.
Clinical, Journal, Head-to-Head: Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension. (Pubmed Central) - Jun 8, 2020
Preservative-free latanoprost-timolol fixed combination T2347 showed noninferior efficacy compared with the preserved comparator and was well tolerated.
- | timolol / generics
Clinical, Journal, Head-to-Head: Non-inferiority of Preservative-free versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients with Open-angle Glaucoma or Ocular Hypertension. (Pubmed Central) - Mar 29, 2019
The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/.
- |||| latanoprost/timolol (T2347) / Thea Laboratories
Trial primary completion date: Efficacy and Safety Assessment of T2347 Versus Xalacom (clinicaltrials.gov) - Mar 18, 2016
P3, N=242, Completed, Sponsor: Laboratoires Thea
http://creativecommons.org/licenses/by-nc-nd/4.0/. Trial primary completion date: Aug 2015 --> Nov 2015
- ||||||| latanoprost/timolol (T2347) / Thea Laboratories
Trial completion: Efficacy and Safety Assessment of T2347 Versus Xalacom (clinicaltrials.gov) - Sep 8, 2015
P3, N=242, Completed, Sponsor: Laboratoires Thea
Trial primary completion date: Aug 2015 --> Nov 2015 Not yet recruiting --> Completed
- |||||||||| latanoprost/timolol (T2347) / Thea Laboratories
New P3 trial: Efficacy and Safety Assessment of T2347 Versus Xalacom (clinicaltrials.gov) - Oct 30, 2014
P3, N=220, Not yet recruiting, Sponsor: Laboratoires Thea